🇺🇸 FDA
Patent

US 8653088

Compositions useful as inhibitors of protein kinases

granted A61PA61P25/28A61P3/10

Quick answer

US patent 8653088 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P25/28, A61P3/10